The 6 key players our Insulin Pens report profiles.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Novo Nordisk A/S |
novo.com (opens in a new tab) | 595 reports |
| 2 | Eli Lilly and Company |
lilly.com (opens in a new tab) | 1,156 reports |
| 3 | Sanofi |
sanofi.com (opens in a new tab) | 1,486 reports |
| 4 | Ypsomed | — | 100 reports |
| 5 | Owen Mumford | — | 50 reports |
| 6 | BD (Becton, Dickinson) |
bd.com (opens in a new tab) | 909 reports |
One report for each place. Each tile opens that place's report.
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.